Home » Senology » History of breast cancer

Read 

 

Read 

 

 

 

 

Official website of the International Senology Oncology Scientific Community

 

 

 

Editor-in-chief: Dr. Gian Paolo Andreoletti - Oncologist, Science Journalist

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



History of breast cancer

1600 BC: The Edwin Smith Papyrus describes the earliest known cases of tumors of the breast, that were treated by cauterization with a tool called the "fire drill". The writing says about the breast disease: "There is no treatment".

 

 

Herodotus (484–425 BC), historian of the wars between Persia and Greece, writes that Democedes, a Persian physician living in Greece, cured the wife of Persian King Darius of an ulcerated breast cancer

 

 

The Roman physician Aulus Cornelius Celsus (42BC – 37AD) described breast carcinoma in his manuscript “De Medicina”. Celsus defined four stages of disease: cacoethes (early stage and surgically curable tumour), carcinoma without skin ulceration, carcinoma with ulceration and advanced exophytic lesion

 

 

Leonides (2nd century AD), a surgeon of the Alexandrian school, was the first to note that breast cancers spread to the axilla

 

 

Galen of Pergamum (129–200 BC) noted that breast carcinomas were frequent in patients who had ceased to menstruate. In Galen’s view, menstruation clears the body of excess black bile, whose accumulation causes cancer

 

 

Between the seventeen and eighteen hundreds,  Jean Petit (Paris)  and Benjamin Bell (Edinburgh) were the first surgeons  to remove the lymph nodes, breast tissue and chest muscle in an effort to save patients from breast carcinoma

 

 

In 1874 the British surgeon and pathologist James Paget makes a brief report describing changes on the nipple that precede the manifestation of breast cancer (Paget’s disease of the nipple)

 

 

Charles H. Moore:, Royal Medical and Chirugical Society, London, 1867: “On the influence of inadequate operations on the theory of cancer", Med Chir Trans 32: 245-80: Taught without doubt by foregoing failures, our surgical ancestors adopted a method of operating which might well have been expected to prove effectual against a local recurrence of the disease. They transfixed the base of the mamma, and, raising it with ligatures, swept off the whole organ, together with all the skin that covered it. The proceeding had a barbarous appearance enough, but it was promising; and, if their knowledge of the disease had led the Surgeons of the time to adopt it before the skin was hopelessly infiltrated, they must have met with more success than they appear to have done. Postponing, however, all operation until the skin was brawny and covered with tubercles, and the deeper textures were involved without limit, they failed too often, with even such extensive cutting as they adopted, to comprehend the entire disease. It was a mistaken kindness which led to a change of this mode of operating. Under the influence of a clergyman, who expressed what must have been a prevailing horror at such Amazonian surgery, the practice was changed to an incision in the integument, which was reflected in flaps and brought together again after the removal of the cancerous tumour. There could have been no diminution of suffering by this prolongation of the operation, and what was gained by it in neatness was lost in life."

 

 

Charles H. Moore:, Royal Medical and Chirugical Society, London, 1867: On the influence of inadequate operations on the theory of cancer", Med Chir Trans 32: 245-80: “It is not sufficient  to remove the cancer  or any portion only of the breast in which it is situated; mammary cancer requires the careful extirpation of the entire organ. It is desirable to avoid not only cutting into the tumor but also seeing it.  No actually morbid texture should be exposed, lest the active microscopic elements in it should be set free and lodge in the wound. Diseased axillary glands should be taken away at the same dissection as the breast itself”. .

 

 

William S Halsted  (New York, 1852-1922),  "The results of radical operations  for the cure of carcinoma of the breast", Ann Surg. July 1907:46(1):1-19: Fortunately we no longer need  the proof which our figures so unmistakably give that the slightest delay is dangerous and that, other things being equal, the prognosis is quite good in the early stage of breast cancer, two in three being cured, and bad, three in four succumbing, when the axillary glands are demonstrably involved"  

 

 

William S Halsted  (New York, 1852-1922),  "The Results of Operations for the Cure of Cancer of the Breast  Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894", Ann Surg. 1894 November; 20(5): 497–555The pectoralis major muscle, entire or all except its clavicular portion, should be excised in every case of cancer of the breast ."

 

 

 

William S Halsted  (New York, 1852-1922),  "The results of radical operations  for the cure of carcinoma of the breast", Ann Surg. July 1907:46(1):1-19": The Operation -  (...) It must be our endeavor to trace more definitely the routes travelled in the metastases to bone, particularly to the humerus, for it is even possible in case of involvement of this bone that amputation of the shoulder joint plus a proper removal of the soft parts might eradicate the disease. So, too, it is conceivable that ultimately, when our knowledge of the lymphatics traversed in cases of femur involvement becomes sufficiently exact, amputation at the hip joint may seem indicated"  

 

 

 

1968 - Bernard Fisher, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA: "The Halsted radical mastectomy, first described in 1894, is a local form of therapy for mammary cancer which, by itself, can cure only those patients whose tumor is confined to the tissues of the chest wall and axilla removed at surgery. Observation in this study of a 5-year recurrence rate of 20 per cent in patients with negative nodes and close to 70 per cent in those with positive nodes emphasizes the inability of conventional radical surgery to eradicate all cancer cells because of their dissemination prior to or at the time of operation. More extensive regional dissection, carried to the limit of feasibility and sensibility, has not produced a substantial improvement in results". (Fisher B et al.: "Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation", Ann Surg. 1968 Sep;168(3):337-56

 

 

 

1976 - Gianni Bonadonna (Milan, Italy): "Our data indicate that patients with potentially curable breast cancer and with positive axillary lymph nodes at the time of mastectomy show a statistically significant reduction in recurrence rate during the first 27 months after radical mastectomy when treated with cyclic prolonged combination chemotherapy. At present, the advantage of CMF appears statistically evident in all subgroups of patients" (Bonadonna G et al.: "Combination chemotherapy as an adjuvant treatment in operable breast cancer ", N Engl J Med. 1976 Feb 19;294(8):405-10)

 

 

 

 

1981 - Umberto Veronesi, National Cancer Institute, Milan, Italy: "A number of different factors may explain the progressive development of new procedures for conservative treatment of breast cancer. The first factor is a better understanding of the natural history of breast cancer and of the fact that the results of treatment are influenced more by distant spread when it occurs than by local or regional control of the disease. The second is the discovery of increasing numbers of cancers of minimal dimensions by means of new diagnostic techniques, especially mammography. The third is the more pressing demand for less mutilating procedures and the increasing requests from patients to be informed of the various possible treatments, including the conservative techniques. Finally, there is a widespread belief that if a conservative treatment could be offered to women with early breast cancer, it would represent a tremendous tool for publicizing self-examination of the breasts and alertness in seeking medical advice at the first appearance of a lump in the breast". (Veronesi U et al.: "Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast", N Engl J Med.1981Jul 2;305(1):6-11)

 

 

 

 

1997 - Umberto Veronesi, European Institute of Oncology, Milan, Italy - "In the large majority of patients with breast cancer, lymphoscintigraphy and gamma-probe-guided surgery can be used to locate the sentinel node in the axilla, and thereby provide important information about the status of axillary nodes. Patients without clinical involvement of the axilla should undergo sentinel-node biopsy routinely, and may be spared complete axillary dissection when the sentinel node is disease-free ". (Veronesi U et al.: "Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes2, Lancet. 1997 Jun 28;349(9069):1864-7)

 

 

 

 

 

 


   Iscriviti al mio canale YouTube          Follow Senology on Twitter